Research Program Contacts
Find NCI Program Director Contacts for the following Divisions, Centers, and Offices. Use the NIH Matchmaker tool to search for projects, contacts, and review panels related to your research across the NIH.
NCI Divisions
Administrative Questions?
Our Grants Management Contacts can address administrative questions about your grants.
Find NCI Staff and Program Director contacts for the following NCI Divisions.
Division of Cancer Biology (DCB)
DCB supports and coordinates research projects in basic cancer biology at universities, hospitals, research foundations, and businesses across the United States and abroad.
DCB Staff Directory
Cancer Cell Biology
Dr. Rihab Yassin
240-276-6230
[email protected]
Cancer Immunology, Hematology and Etiology
Dr. Kevin Howcroft
240-276-6200
[email protected]
DNA and Chromosome Aberrations
Dr. Ian Fingerman
240-276-7002
[email protected]
Biophysics, Bioengineering, and Computational Sciences
Dr. Jennifer Couch
240-276-6210
[email protected]
Tumor Biology and Microenvironment
Dr. Jeffrey Hildesheim
240-276-6220
[email protected]
Tumor Metastasis
Dr. Joanna Watson
240-276-6220
[email protected]
Office of Cancer Genomics (CCG)
CCG supports programs that enhance our understanding of the molecular mechanisms of cancer.
Dr. Liming Yang
[email protected]
240-781-3407
Division of Cancer Control & Population Sciences (DCCPS)
DCCPS supports a comprehensive program of genomic, epidemiologic, behavioral, social, and surveillance cancer research.
Implementation Science
Dr. David Chambers
240-276-5090
[email protected]
Cancer Survivorship
Dr. Emily Tonorezos
[email protected]
Health Disparities Research
Dr. Shobha Srinivasan
240-276-6938
[email protected]
Environmental Epidemiology
Dr. Tram Kim Lam
240-276-6967
[email protected]
Clinical and Translational Epidemiology
Dr. Andrew Freedman
240-276-6697
[email protected]
Genomic Epidemiology
Dr. Elizabeth Gillanders
240-276-6764
[email protected]
Methods and Technologies (Epidemiology & Genomics)
Dr. Mukesh Verma
240-276-6889
[email protected]
Risk Factor Assessment
Dr. Jill Reedy
240-276-6812
[email protected]
Data Quality, Analysis, and Interpretation
Dr. Serban Negoita
240-276-5409
[email protected]
Surveillance Informatics
Dr. Elizabeth Hsu
240-276-5733
[email protected]
Data Analytics
Dr. Angela Mariotto
240-276-6698
[email protected]
Statistical Research and Applications
Dr. Zara Tatalovich
240-276-6976
[email protected]
Basic Biobehavioral and Psychological Sciences
Dr. Paige Green
240-276-6899
[email protected]
Health Communication and Informatics
Dr. Robin C. Vanderpool
240-276-6558
r[email protected]
Health Behaviors
Dr. Susan Czajkowski
240-276-5871
[email protected]
Tobacco Control
Dr. Neal Freedman
240-276-7195
[email protected]
Healthcare Assessment Research
Dr. Lindsey Enewold
240-276-6856
[email protected]
Health Systems and Interventions Research
Dr. Sarah Kobrin
240-276-6931
[email protected]
Outcomes Research
Dr. Ashley Wilder Smith
240-276-6714
[email protected]
Division of Cancer Prevention (DCP)
DCP supports research to determine and reduce a person's risk of developing cancer, as well as research to develop and evaluate cancer screening procedures.
Biometry
Dr. Erin Lavik, Sc.D.
240-276-7057
[email protected]
Breast and Gynecologic Cancer
Dr. Brandy Heckman-Stoddard
240-276-7048
[email protected]
Cancer Biomarkers
Dr. Sudhir Srivastava
240-276-7028
[email protected]
Chemopreventive Agent Development
Dr. Robert Shoemaker
240-276-7077
[email protected]
Dr. Shizuko Sei
240-276-5005
[email protected]
Community Oncology & Prevention Trials
Brandy Heckman-Stoddard, Ph.D., M.P.H.
240-276-7048
[email protected]
Early Detection
Dr. Paul Pinsky
240-276-7014
[email protected]
Gastrointestinal and Other Cancers
Dr. Asad Umar
240-276-7038
[email protected]
Lung and Upper Aerodigestive Cancer
Dr. Eva Szabo
240-276-7011
[email protected]
Nutritional Science
Dr. Robert Shoemaker
240-276-7077
[email protected]
Prostate and Urologic Cancer
Dr. Howard Parnes
240-276-7045
[email protected]
Division of Cancer Treatment and Diagnosis (DCTD)
DCTD supports the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients.
Cancer Diagnosis Program
Dr. Lyndsay Harris
240-276-6327
[email protected]
Cancer Imaging Program
Dr. Janet F. Eary
240-276-5135
[email protected]
Cancer Therapy Evaluation Program
Dr. Meg Mooney
240-276-651
[email protected]
Developmental Therapeutics Program
Dr. Rosemarie Aurigemma
240-276-5465
[email protected]
Complementary and Alternative Medicine
Dr. Jeffrey D. White
240-276-6595
[email protected]
Radiation Research Program
Dr. C. Norman Coleman
240-276-5690
[email protected]
Translational Research Program
Dr. Toby Hecht
240-276-5683
[email protected]
Office of Cancer Clinical Proteomics Research
Dr. Henry Rodriguez
240-781-3370
[email protected]
Office of Nanotechnology Research
Dr. Piotr Grodzinski
301-594-6345
[email protected]
NCI Centers, Offices, and Programs
Find NCI Program Director contacts for the following NCI Centers, Offices, and Selected Programs.
Center for Cancer Training (CCT)
CCT provides funding to support training and career development for cancer researchers working at institutions nationwide and also manages intramural training programs offered at NCI laboratories and offices.
Dr. Oliver Bogler
240-276-5911
[email protected]
Center for Global Health (CGH)
CGH facilitates global collaboration by leveraging research resources with U.S. government agencies, foreign governments, non-government organizations, and pharmaceutical and biotechnology companies.
Dr. Satish Gopal
240-276-5810
[email protected]
Center to Reduce Cancer Health Disparities (CRCHD)
CRCHD strives to achieve health equity by working towards eliminating health disparities, advancing inclusive research across basic, clinical, translational, and population-based studies, promoting a diverse workforce, and enhancing community engagement.
Center for Strategic Scientific Initiatives (CSSI)
CSSI creates opportunities for researchers through the development of new science initiatives, tools, and public resources to accelerate progress in cancer research.
Innovative Molecular Analysis Technologies Program (IMAT)
IMAT is a NCI initiative that supports the development of novel technologies that support clinical, laboratory, and epidemiology cancer research.
Dr. Kelly Crotty
240-781-3310
[email protected]
Office of HIV and AIDS Malignancies (OHAM)
OHAM coordinates HIV/AIDS research throughout the NCI, including programs in AIDS-related cancer.
Dr. Robert Yarchoan
301-496-0328
[email protected]
Small Business & Small Business Technology Transfer (SBIR/STTR)
SBIR and STTR programs seek to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer.
Michael Weingarten
240-276-5238
[email protected]